Adam C, Hassoun A, Defresne C, Guilmot-Bruneau M, Wery-Follet B, Saussez-De Temmerman A
Dermatologica. 1982;165(6):640-6.
Hemin is known as an interesting drug in the treatment of acute attacks of porphyria: this was verified in a case of porphyria variegata. Furthermore, bimestrial perfusion of 500 mg of hemin prevented new biological and clinical deterioration. If confirmed, this schedule would represent a major progress in the management of porphyria variegata.
这在一例迟发性皮肤卟啉病患者中得到了证实。此外,每两个月灌注500毫克氯高铁血红素可防止新的生物学和临床恶化。如果得到证实,这一方案将代表迟发性皮肤卟啉病治疗方面的重大进展。